Categories: Business

Cava Group (CAVA) earnings Q2 2024

Customers arrive at a Cava restaurant in New York City on June 22, 2023.

Brendan Mcdermid | Reuters

Cava on Thursday raised its full-year outlook as its restaurants reported strong traffic, fueling better-than-expected quarterly earnings and revenue.

Shares of the company rose 9% in extended trading. The stock has more than doubled its value this year, bringing Cava’s market cap up to about $11.6 billion, as of Thursday’s close.

Here is what the company reported for the quarter that ended July 14 compared to what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: 17 cents vs. 13 cents expected
  • Revenue: $233 million vs. $220 million expected

The Mediterranean restaurant chain reported fiscal second-quarter net income of $19.7 million, or 17 cents per share, up from $6.5 million, or 21 cents per share, a year earlier.

Net sales climbed 35% to $233 million. The company’s same-store sales rose 14.4%, topping StreetAccount estimates of 7.9%.

While many other restaurant companies have reported declines in visits as consumers pull back their spending, Cava said its traffic grew 9.5% in the quarter. Cava CEO and co-founder Brett Schulman credited the chain’s new grilled steak option as one reason customers kept coming to its restaurants during the quarter.

Cava opened 18 net new locations during the quarter, bringing its total footprint up to 341 restaurants.

For fiscal 2024, Cava now expects same-store sales growth of 8.5% to 9.5%, up from its prior range of 4.5% to 6.5%. The company is also projecting that it will open 54 to 57 new locations this year, up from its previous forecast of 50 to 54 restaurants.

Cava also expects to report adjusted earnings before interest, taxes, depreciation and amortization of $109 million to $114 million. Previously, it was projecting adjusted EBITDA of $100 million to $105 million for the fiscal year.

Don’t miss these insights from CNBC PRO

Times Reporter

Recent Posts

Novo Nordisk points to Cagrilintide’s commitment to search for next obesity drug

The logos of Danish drugmaker Novo Nordisk, maker of blockbuster diabetes and weight loss treatments…

2 days ago

Inside Nicole Kidman, Keith Urban’s first week after filing for divorce

As she navigates this next phase of her life, Kidman remains focused on her work.…

2 days ago

David Ricks, CEO of Eli Lilly, talks about investing in the UK and US

US policymakers should take note that biopharmaceutical companies are withdrawing their investments in the UK.…

3 days ago

NBA commissioner Adam Silver says WNBA games could come to China

MACAO - NBA Commissioner Adam Silver said Friday that the WNBA could play games in…

4 days ago

Trump links autism to the Tylenol ingredient acetaminophen during pregnancy

In this photo illustration, Tylenol capsules are seen on September 22, 2025 in San Anselmo,…

4 days ago

Amgen and other drugmakers are launching DTC programs

The Amgen headquarters in Thousand Oaks, California.Eric Thayer | Bloomberg | Getty ImagesA version of…

5 days ago

This website uses cookies.